Northern Trust’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-884
Closed -$3.32K 4514
2025
Q1
$3.32K Sell
884
-572
-39% -$5.55K ﹤0.01% 4413
2024
Q4
$12.2K Sell
1,456
-306
-17% -$2.91K ﹤0.01% 4414
2024
Q3
$21.2K Hold
1,762
﹤0.01% 4330
2024
Q2
$70.3K Sell
1,762
-35
-2% -$2.31K ﹤0.01% 4134
2024
Q1
$138K Sell
1,797
-148
-8% -$14K ﹤0.01% 3996
2023
Q4
$222K Buy
1,945
+1,165
+149% +$99.6K ﹤0.01% 3865
2023
Q3
$84.3K Buy
+780
New +$118K ﹤0.01% 4052

Other funds holding XAGE

Northern Trust's XAGE Position: Q2 2025 in Review

Northern Trust sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q2 2025, closing a stake of 884 shares — an estimated $3.32K sold.

Northern Trust first reported a position in XAGE in Q3 2023 and held it in 7 quarters. The position peaked at $222K in Q4 2023. 11 funds tracked by Wall St. Rank hold XAGE as of Q2 2025.

  • Northern Trust reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Northern Trust sold 884 Longevity Health Holdings, Inc. Common Stock shares in Q2 2025, an estimated $3.32K.
  • Northern Trust first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2023 and held it in 7 quarters.
  • Northern Trust's Longevity Health Holdings, Inc. Common Stock position peaked at $222K in Q4 2023.
  • 11 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q2 2025.

Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.